TROV

TrovaGene, Inc. News Headlines

$5.85
*  
0.10
1.68%
Get TROV Alerts
*Delayed - data as of Jan. 28, 2015  -  Find a broker to begin trading TROV now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    TROV After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
TrovaGene Partners with Leading Cancer Research Institutes - Analyst Blog
1/26/2015 12:00:00 PM - Investopedia


TrovaGene Partners with Leading Cancer Research Institutes - Analyst Blog
1/26/2015 12:00:00 PM - Zacks.com


Seeking Alpha's Biotech Weekly: Salix Sale Murmurs, A Very Active CHMP, And More
1/23/2015 4:00:00 PM - Seeking Alpha


Health Care Sector Update for 01/21/2015: TROV, UNH, CRIS
1/21/2015 8:42:19 AM - MT Newswires


Trovagene To Participate In Piper Jaffray Healthcare Conference At 11:00 AM ET
12/2/2014 10:02:00 AM - RTT News


TrovaGene Cancer Technology Detects KRAS Mutation - Analyst Blog
11/21/2014 5:35:00 PM - Zacks.com


What's in Store for TrovaGene (TROV) This Earnings Season? - Analyst Blog
11/5/2014 3:40:00 PM - Zacks.com


Can The Uptrend Continue for TrovaGene (TROV)? - Tale of the Tape
9/15/2014 7:49:58 AM - Zacks.com


Increased Earnings Estimates Seen for TrovaGene (TROV): Can It Move Higher? - Tale of the Tape
9/8/2014 7:47:00 AM - Zacks.com


TrovaGene (TROV) Jumps: Stock Rises 9.2% - Tale of the Tape
8/26/2014 8:18:00 AM - Zacks.com


Trovagene reports results from HPV clinical studies
8/25/2014 12:30:00 PM - Seeking Alpha


TrovaGene (TROV) Worth Watching: Stock Rises 8.8% - Tale of the Tape
8/18/2014 8:39:00 AM - Zacks.com


TrovaGene (TROV) Sees Hammer Chart Pattern: Time to Buy? - Tale of the Tape
8/12/2014 9:52:27 AM - Zacks.com


TrovaGene (TROV) is Oversold: Can It Recover? - Tale of the Tape
5/20/2014 9:23:58 AM - Zacks.com


Anthera Pharmaceuticals (ANTH) Jumps: Stock Rises 10.3% - Tale of the Tape
5/16/2014 7:51:00 AM - Zacks.com


bluebird bio (BLUE) Jumps: Stock Adds 27.3% in Session - Tale of the Tape
5/15/2014 8:39:00 AM - Zacks.com


Celldex Therapeutics (CLDX) Soars: Stock Adds 26.9% in Session - Tale of the Tape
5/15/2014 7:51:00 AM - Zacks.com


Tesaro, Inc. (TSRO) Looks Strong as Stock Rallies 21% - Tale of the Tape
5/13/2014 7:44:00 AM - Zacks.com


Endocyte, Inc. (ECYT) in Focus: Stock Rises 5.6% - Tale of the Tape
5/6/2014 7:44:01 AM - Zacks.com


Amicus Therapeutics (FOLD) Jumps: Stock Up 20.7% - Tale of the Tape
4/30/2014 8:39:01 AM - Zacks.com


GTX Inc. (GTXI) Jumps: Stock Up 14.4% - Tale of the Tape
4/30/2014 7:51:01 AM - Zacks.com


Revance Therapeutics (RVNC) Soars: Stock Up 25.8% - Tale of the Tape
4/23/2014 8:39:01 AM - Zacks.com


Cytokinetics, Incorporated (CYTK) Jumps: Stock Up 13.5% - Tale of the Tape
4/22/2014 8:39:01 AM - Zacks.com


TrovaGene (TROV) Enters Oversold Territory - Tale of the Tape
4/16/2014 10:47:01 AM - Zacks.com


Trovagene Is Developing A New Standard Of Care To Manage Cancer, Says CEO
1/21/2014 7:04:00 AM - Seeking Alpha